http://orcid.org/0000-0002-6339-0961
References
- National Institute for Health and Care Excellence. Multiple sclerosis in adults: management. London, UK: NICE guidelines [CG186]. NICE; 2014
- Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care 2011;17:S139-S45
- Utz KS, Hoog J, Wentrup A, et al. Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis. Ther Adv Neurol Disord 2014;7:263-75
- Wicks P, Brandes D, Park J, et al. Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients. Interact J Med Res 2015;4:e6
- Wilson LS, Loucks A, Gipson G, et al. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care 2015;17:74-82
- Bergmann A, Lang M, Bischoff CL, et al. Patient preferences in the choice of disease modifying drugs for multiple sclerosis. Ther Adv Neurol Disord 2014;82(SupplementP3):137
- Ryan M. Using discrete choice experiments to value healthcare programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003;2:55-64
- Ryan M. Discrete choice experiments in healthcare. BMJ 2004;328:360-1
- Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care. Dordrecht: Springer; 2008
- Padania S, Bottomley CJ, Adlard N, et al. Value Health 2015;18:A76
- Shingler S, Swinburn P, Ali S, et al. A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis. J Med Econ 2013;16:1036-42
- Poulos C, Kinter E, Yang JC, et al. Patient preferences for injectable treatments for multiple sclerosis in the United States: a discrete-choice experiment. Patient 2016;9:171-80
- Lynd LD, Traboulsee A, Marra CA, et al. Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study. Ther Adv Neurol Disord 2016;9:287-96
- Garcia-Dominguez JM, Munoz D, Comellas M, et al. Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment. Patient Prefer Adherence 2016;10:1945-56
- Burton R, Fargher E, Plumpton C, et al. Investigating preferences for support with life after stroke: a discrete choice experiment. BMC Health Serv Res 2014;14:63
- Mühlbacher AC, Bethge S. Patients’ preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer. Eur J Health Econ 2015;16:657
- Wong SF, Norman R, Dunning TL, et al. A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia. BMJ Open 2014;4:e006661
- Hall J, Kenny P, King M, et al. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ 2002;11:457-65
- Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics 2008;26:661-77
- Learmonth YC, Motl RW, Sandroff BM, et al. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol 2013;13:13-37
- Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-54
- Louviere J, Hensher DA, Swait J. Stated choice methods: analysis and application. Cambridge, UK: Cambridge University Press; 2000
- Howard K, Salkeld G. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health 2009;12:354-63
- Vass CM, Rigby D, Campbell S, et al. Investigating the framing-effects of risk attributes in discrete choice experiments: a pilot study. Value Health 2014;17:A648
- Heesen C, Kasper J, Segal J, et al. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004;10:643-50
- Mynors G, Suppiah J, Bowen A. Evidence for MS specialist services: findings from the GEMSS MS Specialist Nurse Evaluation Project. Letchworth Garden City, Hertfordshire, UK: MS Trust; 2015